Thank you to our speakers, sponsors, and delegates who joined us in Boston for the summit!
If you are interested in the 2026 event, please get in touch at info@hansonwade.com
Benchmark & Fuse Knowledge from Software, QA, RA & Product Teams to Align Innovation in Software with Evolving Processes, Cybersecurity, & Global Regulatory Frameworks in New & Legacy Devices
Companies Who Attended in 2025:
What You Missed at the 5th Annual Medical Device Software Development Summit 2025
In 2025, the MedTech landscape rapidly evolved, with FDA’s shifting expectations, AI-driven regulations, and global compliance challenges putting pressure on companies to innovate while maintaining security and compliance. With changing U.S. regulations, AI standards, and cybersecurity requirements, it is important to ensure your team is prepared for these challenges. The 5th Medical Device Software Development Summit offered the latest strategies to navigate these uncertainties and stay ahead in a complex, fast-paced industry.
The summit was designed for professionals across all functions - including software development, regulatory affairs, quality assurance, or cybersecurity. Through expert-led sessions and hands-on workshops, attendees gained actionable insights to tackle the latest challenges in AI integration, compliance, and development. No matter your role or organization size, this summit provided the knowledge and tools needed to drive innovation and navigate the complex MedTech landscape.
Unlock strategies to build resilient AI-cybersecurity frameworks amid regulatory uncertainty. Olympus and Retina AI revealed how to secure AI-driven medical devices, integrate cybersecurity into development, and stay ahead of evolving compliance demands.
Streamline global regulatory submissions across the FDA, EU, Japan, and beyond. Leaders from AbbVie and Analog Devices shared strategies to navigate complex approvals, harmonize multi-region submissions, and overcome cross-jurisdictional challenges with confidence.
Future-proof legacy medical devices while ensuring global compliance. Werfen unveiled strategies to mitigate cybersecurity risks, address regulatory gaps, and modernize outdated software systems.
Master SBOM integration and change control for global regulatory compliance. Straumann Group shared best practices for ensuring traceability, managing post-market software changes, and navigating regional regulatory differences.
Harness the potential of closed-loop AI systems for dynamic healthcare environments. Convatec delved into the challenges of building and deploying AI models that continuously adapt through real-time data feedback, ensuring safety, performance, and regulatory compliance throughout the lifecycle.
Eleanora Chakraborty
Associate Director, Regulatory Affairs, Strategic Global Labeling, Combination Products & Devices
Abbvie
What 2024 Attendees Found Valuable:
“Hot topics, high calibre of speakers, and great depth of conversation” Associate Director, Emerging Technologies Regulatory & Quality Lead, Biogen
"The conference exceeded all of my expectations. The diverse formats, and state-of-art topics were engaging and educational. I was extremely fortunate to have made the time to attend the full conference” Vice President, VisCardia
“This event gives insights into the concerns of other medical device companies and their strategies for addressing them” Research, Algorithm & Artificial Intelligence Engineer, Phillips
“There were brilliant people who attended, and they were all willing to share their experiences that will be very helpful to take back to our corporate teams” Senior Lead, Global Regulatory Affairs, Software & Cybersecurity, Fresenius
Our 2025 Partners:
Other Events in the Series:
